Form 4 for CAPR CAPRICOR THERAPEUTICS, INC.
Accepted 2022-04-01 00:00:00 ET · period of report 2022-03-31 · accession 0001415889-22-003580 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-01 | 2022-03-31 | CAPR | Manzo Louis | Dir | F - Tax | $3.43 | -11.3K | 16.6K | -41% | -$38.8K |
| D | 2022-04-01 | 2022-03-31 | CAPR | Manzo Louis | Dir | M - OptEx | $1.39 | +27.9K | 27.9K | New | +$38.8K |
| DM | 2022-04-01 | 2022-03-31 | CAPR | Manzo Louis | Dir | M - OptEx | $0.00 | -27.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-31 | F | D | 11,309 | $3.43 | 16,595 | D | — | — | (F1) Represents a "net exercise" of outstanding stock options. These shares were withheld by the Issuer for payment of the exercise price, based on the closing market price of the Issuer's common stock on March 31, 2022 of $3.43. The options would otherwise expire on April 27, 2022, pursuant to their terms. |
| 2 | Common | Common Stock | 2022-03-31 | M | A | 27,904 | $1.39 | 27,904 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-03-31 | M | D | 15,455 | $0.00 | 0 | D | $1.39 · — to 2022-04-27 | 15,455 Common Stock | (F2) This option was granted on April 27, 2012 and was previously reported as covering 154,555 shares at an exercise price of $0.37 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. (F3) The shares vested 1/48th of the first day of each month, commencing May 1, 2012. |
| 4 | Derivative | Stock Option (Right to Buy) | 2022-03-31 | M | D | 12,449 | $0.00 | 0 | D | $1.39 · — to 2022-04-27 | 12,449 Common Stock | (F4) This option was granted on April 27, 2012 and was previously reported as covering 124,491 shares at an exercise price of $0.37 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020. (F5) The shares vested immediately. |